Crispr Stock Rises, As Intellia Surges, On New Promise For Gene Editing

Health

Crispr Stock Rises, As Intellia Surges, On New Promise For Gene Editing

By Investor's Business Daily

Crispr stock jumped Monday while Intellia shares surged on promising updates for their gene-editing efforts in cholesterol treatment and a swelling disorder. At American Heart Association conference in New Orleans, Crispr Therapeutics (CRSP) said a s ...Read more

Related Posts

'We had no clue:' Mark Spain's wife recounts his symptoms before pancreatic cancer

'We had no clue:' Mark Spain's wife recounts his symptoms before pancreatic cancer

Nov 03, 2025
Scientists Say They've Figured Out a Way to Reprogram the Pancreas to Produce GLP-1s Without Ozempic

Scientists Say They've Figured Out a Way to Reprogram the Pancreas to Produce GLP-1s Without Ozempic

Nov 09, 2025
UFC 322 roundtable: Will Islam Makhachev and Zhang Weili join the champ-champ list?

UFC 322 roundtable: Will Islam Makhachev and Zhang Weili join the champ-champ list?

Nov 09, 2025
Trump strikes deal with Eli Lilly, Novo Nordisk

Trump strikes deal with Eli Lilly, Novo Nordisk

Nov 06, 2025
We use cookies to help provide you with the best experience when you visit our websites. By using this site you consent to the use of cookies on your device. see our cookie policy.